-
Mashup Score: 1U.S. Tuberculosis Cases Rose in 2022: CDC - 2 year(s) ago
THURSDAY, March 23, 2023 (HealthDay News) — Tuberculosis cases climbed again in 2022, U.S. health officials announced Thursday.Still, the 5% increase, which amounted to 8,300 cases, didn’t reach higher pre-pandemic numbers, according to the U.S. Centers for Disease Control and Prevention. “The mess…
Source: Consumer Health News | HealthDayCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1
This webinar will provide updates on innovations in the treatment and prevention of HIV and tuberculosis (TB) co-infections, including the World Health Organization’s (WHO’s) recently published module in its consolidated guidelines on TB: drug-resistant tuberculosis treatment 2022 update. Participants will hear from MedAccess about an agreement to reduce the price of a recently announced…
Source: ZoomCategories: HIV/AIDS, Latest HeadlinesTweet-
💻 Our #webinar on “#HIV and #TB co-infections: Latest updates & innovations” is starting right now! ☑️ It's not too late to attend. Register & join now! https://t.co/HYKIt9oCIU
-
-
Mashup Score: 0
This webinar will provide updates on innovations in the treatment and prevention of HIV and tuberculosis (TB) co-infections, including the World Health Organization’s (WHO’s) recently published module in its consolidated guidelines on TB: drug-resistant tuberculosis treatment 2022 update. Participants will hear from MedAccess about an agreement to reduce the price of a recently announced…
Source: ZoomCategories: HIV/AIDS, Latest HeadlinesTweet-
📣 #Webinar Starting in 1 Hour -- “#HIV and #TB co-infections: Latest updates and innovations”. ✅ Register now! https://t.co/HYKIt9oCIU
-
-
Mashup Score: 1
This webinar will provide updates on innovations in the treatment and prevention of HIV and tuberculosis (TB) co-infections, including the World Health Organization’s (WHO’s) recently published module in its consolidated guidelines on TB: drug-resistant tuberculosis treatment 2022 update. Participants will hear from MedAccess about an agreement to reduce the price of a recently announced…
Source: ZoomCategories: HIV/AIDS, Latest HeadlinesTweet-
Join leading experts tomorrow starting at 14:00 CEST for an online discussion exploring the latest updates and innovations related to#HIV and #TB co-infections. ✅ Learn more about this #webinar and register for free now! https://t.co/HYKIt9oCIU
-
-
Mashup Score: 0
This webinar will provide updates on innovations in the treatment and prevention of HIV and tuberculosis (TB) co-infections, including the World Health Organization’s (WHO’s) recently published module in its consolidated guidelines on TB: drug-resistant tuberculosis treatment 2022 update. Participants will hear from MedAccess about an agreement to reduce the price of a recently announced…
Source: ZoomCategories: HIV/AIDS, Latest HeadlinesTweet-
💻 Join the IAS Educational Fund for a free #webinar this coming Tuesday, 4 April starting at 14:00 CEST on “#HIV and #TB co-infections: Latest updates and innovations”. ✅ Learn more about the agenda, confirmed featured speakers and register now! https://t.co/HYKIt9oCIU
-
-
Mashup Score: 5
A recent study led by Dr. Susmita Chatterjee from The George Institute of Global Health, India, has shed light on the long-term economic impact of TB on patients, even a year after the end of treatment. The study has also shown that India still has a long way to go to reach the goal of zero catastrophic costs for all patient groups, as stated in the END TB Strategy. As an outcome of the…
Source: medicalxpress.comCategories: General Medicine News, Latest HeadlinesTweet-
Study: India has a long way to reach zero catastrophic costs goal for #TB patients @georgeinstitute @PLOSGPH https://t.co/AQhlseWoG8
-
-
Mashup Score: 6Clock is ticking: Urgent science-backed actions needed to end TB - The Sunday Guardian Live - 2 year(s) ago
Every new case of TB infection is a grim reminder of what we could have averted if infection control measures were more effective, including treating
Source: The Sunday Guardian LiveCategories: HIV/AIDS, Latest HeadlinesTweet-
In the @SundayGuardian, IAS Governing Council member @drgilada has penned a new viewpoint -- "Clock is ticking: Urgent science-backed actions needed to end #TB". https://t.co/6h4ywDxFdd
-
-
Mashup Score: 0Revealing Gaps in Our Understanding of Finding Children With TB and Our Ability to Inform Policy - 2 year(s) ago
Tuberculosis (TB) has only recently been officially recognized as a top 10 cause of age under-5 mortality globally.1 The vast majority of the 216 000 children who die each year from TB are never diagnosed with TB.2,3 TB often presents differently in children than adults, and microbiological tests have low sensitivity in children,4 making case detection a major problem. Therefore, identifying…
Source: American Academy of PediatricsCategories: Latest Headlines, PulmonologyTweet-
Revealing Gaps in Our #Understanding of Finding #Children With #TB and Our Ability to Inform #policy https://t.co/bqo8bRciRj https://t.co/3cQRJO3Txd
-
-
Mashup Score: 0HaystackAnalytics rolls out India's first-of-its-kind TB Fundraising Campaign to combat TB-led Deaths in India - 2 year(s) ago
Mumbai (Maharashtra) [India], March 24 (ANI/NewsVoir): With a sharp focus on the eradication of tuberculosis in India this World TB Day, HaystackAnalytics, an IIT Bombay-based health-tech startup, supported by the Department of Science & Technology, Govt. of India, has launched a fundraising campaign to raise awareness on drug-resistant TB which requires a Universal drug susceptibility test (DST)…
Source: ANI NewsCategories: Future of Medicine, Latest HeadlinesTweet-
.@HaystackLab rolls out #India's first-of-its-kind #TB Fundraising Campaign to combat TB-led Deaths in India https://t.co/wF5mQB1sRV
-
-
Mashup Score: 5Adjunctive dexamethasone treatment in adults with listeria monocytogenes meningitis: a prospective nationwide cohort study - 2 year(s) ago
Adjunctive dexamethasone is associated with an improved outcome in patients with L. monocytogenes meningitis and should not be withheld if L. monocytogenes is suspected or detected as causative pathogen.
Source: EClinicalMedicineCategories: Infectious Disease, Latest HeadlinesTweet-
When it comes to treatment of #meningitis I have only used dexamethasone for S.pneumoniae or #TB meningitis. This new study in @eClinicalMed shows dexamethasone is associated with an improved outcome in patients with #Listeria meningitis. https://t.co/e9iEAcxsXw
-
RT @HCETORG: U.S. Tuberculosis Cases Rose in 2022: CDC https://t.co/DASRxwSNgq @CDC_TB @WHO @HealthDayTweets #TB #disparities